About Intrexon Corporation (NYSE:XON)
Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company's domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing (LEAP), and ActoBiotics platform.
Industry, Sector and Symbol
Industry Biotechnology & Medical Research
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$190.93 million
Price / Sales8.43
Price / CashN/A
Book Value$4.58 per share
Price / Book2.91
Return on Equity-18.68%
Return on Assets-11.34%
Frequently Asked Questions for Intrexon Corporation (NYSE:XON)
What is Intrexon Corporation's stock symbol?
Intrexon Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "XON."
How were Intrexon Corporation's earnings last quarter?
Intrexon Corporation (NYSE:XON) announced its quarterly earnings results on Wednesday, May, 10th. The biotechnology company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.04. The biotechnology company earned $53.70 million during the quarter, compared to the consensus estimate of $49.08 million. Intrexon Corporation had a negative return on equity of 18.68% and a negative net margin of 66.88%. The company's revenue for the quarter was up 23.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.55) EPS. View Intrexon Corporation's Earnings History.
When will Intrexon Corporation make its next earnings announcement?
Where is Intrexon Corporation's stock going? Where will Intrexon Corporation's stock price be in 2017?
6 brokers have issued 12-month price targets for Intrexon Corporation's stock. Their forecasts range from $21.00 to $57.00. On average, they expect Intrexon Corporation's share price to reach $38.50 in the next year. View Analyst Ratings for Intrexon Corporation.
Who are some of Intrexon Corporation's key competitors?
Some companies that are related to Intrexon Corporation include Ligand Pharmaceuticals Incorporated (LGND), Blueprint Medicines Corporation (BPMC), Ironwood Pharmaceuticals (IRWD), Spectrum Pharmaceuticals (SPPI), Foundation Medicine (FMI), Immunomedics (IMMU), Global Blood Therapeutics (GBT), Esperion Therapeutics (ESPR), Medpace Holdings (MEDP), Genus plc (GNS), Editas Medicine (EDIT), Arena Pharmaceuticals (ARNA), Momenta Pharmaceuticals (MNTA), Genomic Health (GHDX), WAVE Life Sciences (WVE), Albany Molecular Research (AMRI), Biohaven Pharm (BHVN) and Heron Therapeutics (HRTX).
Who are Intrexon Corporation's key executives?
Intrexon Corporation's management team includes the folowing people:
- Randal J. Kirk, Chairman of the Board, Chief Executive Officer (Age 63)
- Thomas D. Reed Ph.D., Founder, Chief Science Officer (Age 51)
- Rick L. Sterling CPA, Chief Financial Officer (Age 53)
- Andrew J. Last Ph.D., Chief Operating Officer (Age 57)
- Joel Liffmann, Senior Vice President - Finance (Age 56)
- Jack Anthony Bobo, Senior Vice President, Chief Communications Officer (Age 51)
- Ena Chan Cratsenburg, Senior Vice President - Consumer Sector (Age 48)
- Nir Nimrodi, Senior Vice President - Corporate Development (Age 48)
- Jeffrey T. Perez, Senior Vice President — Intellectual Property Affairs (Age 45)
- Christopher Basta, Vice President - Investor Relations
Who owns Intrexon Corporation stock?
Intrexon Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Third Security LLC (46.88%), Iridian Asset Management LLC CT (3.06%), First Trust Advisors LP (1.32%), Peregrine Capital Management LLC (0.48%), Bank of New York Mellon Corp (0.20%) and Schwab Charles Investment Management Inc. (0.16%). Company insiders that own Intrexon Corporation stock include Andrew J Last, Dean J Mitchell, Donald P Lehr, Fred Hassan, Jeffrey Thomas Perez, Joel D Liffman, Nir Nimrodi, Randal J Kirk, Robert B Shapiro and Suma Krishnan. View Institutional Ownership Trends for Intrexon Corporation.
Who sold Intrexon Corporation stock? Who is selling Intrexon Corporation stock?
Intrexon Corporation's stock was sold by a variety of institutional investors in the last quarter, including Third Security LLC, Frontier Capital Management Co. LLC, Iridian Asset Management LLC CT, Stifel Financial Corp, Lagoda Investment Management L.P., Advisors Asset Management Inc., Schwab Charles Investment Management Inc. and Ladenburg Thalmann Financial Services Inc.. View Insider Buying and Selling for Intrexon Corporation.
Who bought Intrexon Corporation stock? Who is buying Intrexon Corporation stock?
Intrexon Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Commonwealth Equity Services Inc, Peregrine Capital Management LLC, GSA Capital Partners LLP, JPMorgan Chase & Co., First Trust Advisors LP, First Washington CORP, Trellus Management Company LLC and Fox Run Management L.L.C.. Company insiders that have bought Intrexon Corporation stock in the last two years include Andrew J Last, Dean J Mitchell, Donald P Lehr, Fred Hassan, Jeffrey Thomas Perez, Joel D Liffman, Nir Nimrodi, Randal J Kirk and Robert B Shapiro. View Insider Buying and Selling for Intrexon Corporation.
How do I buy Intrexon Corporation stock?
Shares of Intrexon Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Intrexon Corporation's stock price today?
One share of Intrexon Corporation stock can currently be purchased for approximately $13.34.
How big of a company is Intrexon Corporation?
Intrexon Corporation has a market capitalization of $1.61 billion and generates $190.93 million in revenue each year. The biotechnology company earns $-186,610,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Intrexon Corporation employs 935 workers across the globe.
How can I contact Intrexon Corporation?
Intrexon Corporation's mailing address is 1750 Kraft Dr Ste 1400, BLACKSBURG, VA 24060-6147, United States. The biotechnology company can be reached via phone at +1-301-5569809 or via email at [email protected]
MarketBeat Community Rating for Intrexon Corporation (XON)MarketBeat's community ratings are surveys of what our community members think about Intrexon Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Intrexon Corporation (NYSE:XON) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 1 Hold Rating, 5 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 2.83)|
|Consensus Price Target: ||$38.50 (188.61% upside)|
Consensus Price Target History for Intrexon Corporation (NYSE:XON)
Analysts' Ratings History for Intrexon Corporation (NYSE:XON)
(Data available from 11/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|11/10/2017||Northland Securities||Reiterated Rating||Buy||$21.00||N/A|
|11/10/2017||Bank of America Corporation||Lower Price Target||Neutral||$25.00 -> $21.00||N/A|
|11/10/2017||Stifel Nicolaus||Boost Price Target||Buy||$39.00 -> $57.00||N/A|
|10/6/2017||Griffin Securities||Reiterated Rating||Buy||$55.00||N/A|
|10/5/2017||JMP Securities||Reiterated Rating||Outperform||$42.00||N/A|
|3/14/2017||Wunderlich||Lower Price Target||Buy||$50.00 -> $35.00||High|
|11/11/2016||J P Morgan Chase & Co||Reiterated Rating||Hold||N/A|
|3/1/2016||Mizuho||Reiterated Rating||Neutral||$28.00 -> $29.00||N/A|
Earnings History and Estimates Chart for Intrexon Corporation (NYSE:XON)
Earnings History by Quarter for Intrexon Corporation (NYSE XON)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/7/2018|| || || || || || || || |
|8/9/2017||Q2 2017||($0.21)||($0.16)||$57.17 million||$54.40 million||View||Listen|
|5/10/2017||Q1 2017||($0.22)||($0.26)||$49.08 million||$53.70 million||View||N/A|
|3/1/2017||Q416||($0.23)||($0.37)||$52.53 million||$46.00 million||View||Listen|
|11/9/2016||Q316||($0.21)||($0.24)||$51.70 million||$48.99 million||View||Listen|
|8/9/2016||Q216||($0.26)||($0.42)||$53.78 million||$52.50 million||View||N/A|
|5/10/2016||Q1||($0.20)||($0.55)||$46.26 million||$43.40 million||View||Listen|
|2/29/2016||Q415||($0.18)||($0.28)||$41.82 million||$41.50 million||View||Listen|
|11/9/2015||Q3||($0.21)||($0.34)||$40.84 million||$53.40 million||View||N/A|
|8/10/2015||Q215||($0.04)||$0.01||$55.93 million||$44.90 million||View||Listen|
|5/11/2015||Q115||($0.12)||$0.25||$32.90 million||$33.80 million||View||Listen|
|3/2/2015||Q414||($0.16)||$0.18||$26.11 million||$31.10 million||View||N/A|
|11/13/2014||Q314||($0.16)||($0.53)||$19.40 million||$21.20 million||View||N/A|
|8/14/2014||Q214||($0.13)||($0.11)||$9.39 million||$11.80 million||View||N/A|
|5/7/2014||Q1||$0.06||$0.04||$11.25 million||$7.90 million||View||N/A|
|3/31/2014||Q413||($0.14)||($0.13)||$8.38 million||$7.10 million||View||N/A|
|11/7/2013||($0.03)||$0.15||$9.79 million||$6.10 million||View||N/A|
Earnings Estimates for Intrexon Corporation (NYSE:XON)
2017 EPS Consensus Estimate: ($0.85)
2018 EPS Consensus Estimate: ($0.75)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Intrexon Corporation (NYSE:XON)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Intrexon Corporation (NYSE XON)
Insider Ownership Percentage: 56.30%
Institutional Ownership Percentage: 77.17%
Insider Trades by Quarter for Intrexon Corporation (NYSE XON)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/13/2017||Andrew J Last||COO||Buy||2,000||$12.10||$24,200.00|| |
|8/22/2017||Robert B Shapiro||Director||Buy||2,850||$17.50||$49,875.00|| |
|8/14/2017||Andrew J Last||COO||Buy||2,000||$19.99||$39,980.00|| |
|8/11/2017||Dean J Mitchell||Director||Buy||5,000||$18.33||$91,650.00|| |
|8/11/2017||Donald P Lehr||Insider||Buy||1,094||$18.33||$20,053.02|| |
|8/11/2017||Jeffrey Thomas Perez||SVP||Buy||1,000||$17.89||$17,890.00|| |
|8/11/2017||Randal J Kirk||CEO||Buy||132,625||$18.85||$2,499,981.25|| |
|12/13/2016||Randal J Kirk||CEO||Buy||34,606||$28.90||$1,000,113.40|| |
|12/12/2016||Joel D Liffman||SVP||Buy||8,500||$28.62||$243,270.00|| |
|12/1/2016||Fred Hassan||Director||Buy||6,900||$29.02||$200,238.00|| |
|8/29/2016||Nir Nimrodi||SVP||Buy||4,000||$26.12||$104,480.00|| |
|5/13/2016||Randal J Kirk||CEO||Buy||41,830||$23.92||$1,000,573.60|| |
|12/11/2015||Randal J Kirk||CEO||Buy||124,475||$29.85||$3,715,578.75|| |
|12/7/2015||Randal J Kirk||CEO||Buy||237,525||$30.69||$7,289,642.25|| |
|12/4/2015||Suma Krishnan||SVP||Sell||20,900||$35.66||$745,294.00|| |
|1/27/2015||Randal J Kirk||CEO||Buy||555,556||$27.00||$15,000,012.00|| |
|5/13/2014||Donald Lehr||Insider||Buy||1,850||$15.99||$29,581.50|| |
|5/13/2014||Randal Kirk||CEO||Buy||65,173||$15.19||$989,977.87|| |
|5/9/2014||Kelly Huang||SVP||Buy||3,200||$15.78||$50,496.00|| |
|5/9/2014||Krish Krishnan||COO||Buy||20,900||$14.21||$296,989.00|| |
|3/27/2014||Randal Kirk||CEO||Buy||243,001||$25.72||$6,249,985.72|| |
|3/4/2014||Gregory Ian Frost||SVP||Buy||100,000||$25.95||$2,595,000.00|| |
|8/13/2013||Jeffrey B Kindler||Director||Buy||33,000||$16.00||$528,000.00|| |
|8/13/2013||Randal J Kirk||CEO||Buy||1,887,500||$16.00||$30,200,000.00|| |
|8/13/2013||Thomas D Reed||Insider||Buy||1,800||$16.00||$28,800.00|| |
|8/13/2013||Thomas R Kasser||SVP||Buy||5,000||$16.00||$80,000.00|| |
Latest Headlines for Intrexon Corporation (NYSE XON)
Intrexon Corporation (NYSE XON) Chart for Thursday, November, 23, 2017